EMCURE — Emcure Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- IN₹345.39bn
- IN₹359.40bn
- IN₹92.04bn
Brief: Emcure Pharmaceuticals And Sanofi India Announce Distribution Partnership For Diabetes Drugs
Brief: Emcure Pharmaceuticals Says US FDA Conducted PAI At Emcure's Sanand Facility
India's Emcure Pharmaceuticals falls after block deals at discount
India's Emcure Pharma extends gains on Q4 profit jump
Brief: Emcure Pharmaceuticals Approves Incorporation Of Subsidiary Emcure Generics
Brief: Emcure Pharmaceuticals Receives EIR From USFDA
Brief: Emcure Pharmaceuticals Says Tillomed Acquires Strategic Pharma Portfolio From Manx
Brief: Emcure Pharmaceuticals Says Emcutix And Wiqo Sign Exclusive Licensing Partnership
Media: Bain Capital looks to sell over $200 million worth stake in Emcure Pharmaceuticals via block deal - Mint
Brief: Emcure Pharmaceuticals Says USFDA Inspection At API Manufacturing Maharashtra Facility
India's Emcure Pharma gains on Q3 profit jump
Brief: Emcure Pharmaceuticals Inaugurates Research And Development Centre In Gujarat
India's Emcure Pharma jumps after Kotak upgrades to 'buy' on upbeat growth prospects
India's Emcure Pharma gains on Q2 profit, revenue rise
Brief: Emcure Pharmaceuticals Sept-Quarter Consol Net Profit 1.95 Bln Rupees
Gilead signs deals with 6 generic drugmakers to sell HIV drug in low-income countries
India's Emcure Pharma hits record high as Kotak initiates with 'Add'
Jefferies cautious on Indian markets due to 'unsustainably high' domestic inflows
Jefferies cautious on Indian markets due to 'unsustainably high' domestic inflows